Andrew Goldstein
Gynecology · Washington, DCNPI 1811041411
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $145,270 of the $156,339 with a category attached, or 92.9%. 10 manufacturers reported payments, led by LEO Pharma AS at 55.9% of the total. 2025 is the largest year on record at $93,180, more than ten times the $280 reported in 2019.
Across 24 payments — averaging $6514.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma AS$87K
- Incyte Corporation$51K
- Ipsen Innovation$10K
- AbbVie$7K
- Therapeuticsmd, Inc.$260
- Merz Pharmaceuticals, LLC$150
- plus $202 from 4 others
Across 61 payments — averaging $7130.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$339K
- Ipsen Innovation$93K
- AbbVie$3K
What the payments were for
- Consulting fees$145,27093%
- Speaking & faculty fees$10,2607%
- Travel & lodging$1100%
- Food & beverage$5650%
- Education$1330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma AS | 3 | $87,320 |
| Incyte Corporation | 3 | $50,700 |
| Ipsen Innovation | 3 | $10,456 |
| AbbVie | 1 | $7,250 |
| Therapeuticsmd, Inc. | 2 | $260 |
| Merz Pharmaceuticals, LLC | 1 | $150 |
| AMAG Pharmaceuticals, Inc. | 7 | $133 |
| Millicent US Inc | 2 | $26 |
| Duchesnay USA Incorporated | 1 | $23 |
| Scynexis, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few gynecology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $1,240 |
| Clobetasol Propionate | 13 | $811 |
| Fluconazole | 12 | $421 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Washington
- Gaby MoawadWashington$1.5M
- James SimonWashington$811K
- Anthony ScialliWashington$165K
- Marilyn JeromeWashington$14K
- Erica DavenportWashington$13K
- Julian SafranWashington$6K
- Sharon MaloneWashington$3K
- Alyssa Small LayneWashington$3K
- Bandhana BajajWashington$2K
- George SammanWashington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.